#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenocortical carcinoma Retinal dystrophy Piriformis syndrome Hereditary neuropathic amyloidosis Transferrin decreased Waldenstrom's macroglobulinaemia recurrent Cutaneous T-cell lymphoma stage II Atypical haemolytic uraemic syndrome Andersen-Tawil syndrome Squamous cell carcinoma of the hypopharynx Liposarcoma Neuroblastoma recurrent Factor VIII deficiency B-cell type acute leukaemia Shprintzen-Goldberg syndrome More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Life with Disease Basal cell naevus syndrome – Trials in Disease Brain stem glioma – Diagnostics Primary hyperoxaluria – Treatment Shprintzen-Goldberg syndrome Arterial tortuosity syndrome – Trials in Disease Soft tissue sarcoma Acquired haemophilia – Treatment Hepatoblastoma – Diagnostics Hepatic angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ixazomib Citrate Fexofenadine Gallium (68Ga) Chloride Doxycycline Hyclate Aluminium Oxide RO7268489 Jk08 Urapidil Dexamethasone Ph. Eur. ICEF15 Pabinafusp Alfa Ibuprofen Arginine Human Apotransferrin Doxecitine Nivolumab Metformin Catequentinib Dihydrochloride Palopegteriparatide 68Ganota-Anti-Her2 Vhh1 Olanzapine More therapies…

    Learn about Your Condition

    Encephalitis autoimmune Progressive supranuclear palsy Adenomatous polyposis coli Mucopolysaccharidosis III Venous thrombosis Inguinal hernia Small cell carcinoma Anal fistula Short-bowel syndrome Renal cancer recurrent Vulvovaginal dryness Hidradenitis Peritoneal cancer index Small intestine adenocarcinoma Craniocerebral injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Regional Du Cancer De Montpellier

Institut Regional Du Cancer De Montpellier

208 Avenue Des Apothicaires, Montpellier, 34298, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Dabrafenib
    • Siremadlin
    • Trametinib
    France

  • Study on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Cisplatin
    France

  • Study of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Cisplatin
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    France

  • Study of LY3537982 for Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • 2-AMINO-4-[(4AS)-8-CHLORO-10-FLUORO-2,3,4,4A,5,6-HEXAHYDRO-12-OXO-3-(1-OXO-2-PROPEN-1-YL)-1H,12H-PYRAZINO[2,1-D][1,5]BENZOXAZOCIN-9-YL]-7-FLUORO-BENZO[B]THIOPHENE-3-CARBONITRILE
    • Ly3537982
    • Cetuximab
    France

  • Study on Immunotherapy with Nivolumab and Ipilimumab for Patients with Recurrent Head and Neck Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Amlodipine Besilate
    • Arginine Hydrochloride
    • Edotreotide
    France

  • Study on STC-1010 and Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Hct116-A
    • Hct116-B
    Belgium France

  • Study of avelumab and cetuximab combination treatment after TPEx chemotherapy for patients with recurrent or metastatic head and neck cancer receiving first-line therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    France

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Temozolomide
    • Vinorelbine Tartrate
    Austria Belgium Czechia Denmark Finland France +10
Previous Page
1 … 4 5 6 7 8 … 25
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!